NovaBay Pharmaceuticals, Inc. Announces Executive Appointments
November 12, 2021 at 06:02 am EST
Share
In connection with the completion of the acquisition of DERMAdoctor, on November 5, 2021, NovaBay Pharmaceuticals, Inc. announced that Drs. Audrey Kunin and Jeff Kunin were appointed to serve as DERMAdoctor's Chief Product Officer and President, respectively. Dr. Audrey Kunin, age 62, co-founded DERMAdoctor and has served as the Chief Creative Officer of DERMAdoctor since March 2018 and as the Chief Executive Officer and its predecessor since 1998. Dr. Jeff Kunin, age 59, co-founded DERMAdoctor and has served as the President and Chief Executive Officer of DERMAdoctor since March 2018.
NovaBay Pharmaceuticals, Inc. is a pharmaceutical company that develops and sells consumer products for the eyecare and skincare markets. The Company's lead product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is proven in laboratory testing to have antimicrobial properties as it removes foreign material, such as microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is formulated with its form of hypochlorous acid and is cleared by the United States Food and Drug Administration (FDA) for sale in the United States. Its other eyecare products offered under the Avenova eyecare brand include Novawipes by Avenova, Avenova Lubricant Eye Drops, Avenova Moist Heating Eye Compress and the i-Chek. Avenova Spray is available both over-the-counter and as a prescription. Avenova Spray is also available at optometrists and ophthalmologists offices; at national pharmacy chains across all over 50 states, and through its Partner Pharmacy Program.
NOVABAY PHARMACEUTICALS 